Adenovirus is the most frequently used virus in gene therapy clinical trials. There have been conflicting reports on the ability of adenovirus to transduce primary ovarian cancer samples and the expression of relevant cell surface molecules. These factors were examined using primary ovarian cancer cells cultured from ascites and solid tumor to gain insights into the clinical use of adenovirus in ovarian cancer. The level of transduction of primary cultures was much higher than uncultured cells and established cell lines, and correlated with higher levels of coxsackie-adenovirus receptor (CAR) and integrin expression. Growth of primary cultures in autologous ascitic fluid prevented an increase in CAR expression and inhibited transduction compared with cells treated in supplemented RPMI. Cells at the periphery of solid tumor samples were transduced using a replication-incompetent virus and correlated with CAR expression. However, transduction was abolished by autologous ascitic fluid, despite the expression of CAR. We conclude that the use of adenoviruses for ovarian cancer gene therapy will require testing in the presence of inhibitory factors in ascitic fluid. The clinical use of adenoviral vectors may require circumvention of such inhibitory factors and the use of replication competent adenovirus to enable efficient viral penetration of the cancer.
Introduction
Epithelial ovarian cancer (EOC) is both the fourth most common cancer and the fourth biggest killer in British women. After primary management with surgery and platinum-based chemotherapy, recent phase III trials report a median progression-free survival between 15 and 24 months (ICON group, 2002 1 ). However, after relapse, and despite the use of further chemotherapy, disease progression leading to the death of the patient is inevitable. In 2005, 44400 deaths from ovarian cancer were reported in the United Kingdom (CancerStats, 2007) . The need for novel therapeutic strategies in the management of EOC is clear.
Gene therapy using viral vectors has been developed toward this end and has been used in vitro to deliver a wide range of therapeutic strategies such as immune modulation, pro-drug activation, or tumor-selective viral replication. The serotype 5 adenovirus is one of the most frequently used viral vectors because of its high transgene expression and its ability to accommodate large transgenes. In addition, these adenoviruses can be manufactured to high titer and have an established safety profile. A number of clinical trials using adenoviral vectors have been performed in EOC with direct intraperitoneal administration. [2] [3] [4] [5] [6] Delivery of adenoviral vectors through an intraperitoneal route has been well tolerated in gene therapy trials and the virus has an excellent safety record when used correctly. EOC is generally confined to the peritoneal cavity and, therefore, is ideally suited to intraperitoneal therapy. Intraperitoneal dissemination is the most common characteristic of EOC and malignant cells generally implant in sites of stasis along the peritoneal fluid circulation. The ascites that may occur in FIGO stage II ovarian carcinomas are a useful tool for studying the disease. The fluid can be easily obtained at surgery or therapeutic paracentesis. The cells it contains are readily cultured and retain the characteristics of the primary tumor. 7, 8 There have been conflicting reports on the applicability of adenoviral vectors to target ovarian cancer cells and the expression of two important molecules involved in adenoviral transduction of cells. The coxsackie-adenovirus receptor (CAR) has been shown to be the primary receptor for adenoviral attachment to the cell and integrins, such as a v b 3 are required for efficient internalization of the virus. 9, 10 The transduction of 25 ovarian cancer cell lines established from patient samples was reported to be low and correlated with low expression of the b 3 integrin subunit involved in internalization of the virus. 11 In contrast, on a panel of five ovarian cancer cell lines analyzed by flow cytometry and immunohistochemisty, the expression of the primary receptor, CAR, was found to be essential for adenoviral transduction efficiency, whereas integrin expression was not limiting. 12 Immunohistochemisty on ovarian cancer tissue from 37 patients with varying disease status showed that 97% were positive for CAR expression, whereas stromal and endothelial cells of the tumor were negative. 13 In addition, 62 and 65% of tumor tissues expressed a v b 3 and a v b 5 , respectively. In 2003, Hemminki et al.
14 showed expression of CAR to be low in advanced clinical tumors using TAG-72-selected cells from ascitic fluid. Further work from this group showed the dependence of adenoviral transduction on the presence of CAR by examining two ovarian cancer cell lines that differed only in their expression of CAR. 15 The primary aim of this study was to evaluate the factors influencing adenoviral transduction in primary cultures and solid tumor that may be important when considering the administration of adenoviral-delivered gene therapy to the peritoneal cavity of patients with EOC. A number of groups have shown the relatively efficient in vitro growth of malignant epithelial cells from ascites, with relatively rare outgrowth of fibroblast cells. 16, 17 In addition, there have also been reports of mesothelial cells outgrowing the malignant epithelial cells with passage. 8, 18 A further aim of the study was, therefore, to establish that the cells collected from the ascitic fluid were of epithelial ovarian origin.
Materials and methods
Cell culture and establishment of ovarian ascites cultures A total of 31 ovarian cancer patients at St James's Hospital participated in this study. The age at diagnosis ranged from 49-90 years with a median age of 63 years old. Eight were peritoneal in origin, 14 were ovarian, and 9 patients had an unknown site of primary tumor. One cancer was FIGO stage 2, 19 were stage 3, and 5 were stage 4. Three patients presented with grade 1 tumor, 6 with grade 2, 10 with grade 3, and the grade of three cancers was not known. The majority of cancers had a serous morphology. The majority of patients were resistant or refractory to platinum-based treatments. Ascitic fluid from these patients was centrifuged to collect the ascites cells. The cells were treated with red blood cell lysis solution for 10 min at room temperature unless no red blood cells were observed. The cells were washed with PBS, then plated in RPMI 1640 supplemented with 15% fetal calf serum (FCS), 1% penicillin/streptomycin, 1% fungizone, and 1% L-glutamine (supplemented RPMI).
Solid tumor tissue was minced and plated in supplemented RPMI until enough cells had spread from the tissue to form a culture. After the cells had adhered to the tissue culture flasks, they were cultured in the supplemented RPMI medium. The ascitic fluid was retained after the removal of the cells and stored at À80 1C. For some experiments, cells were cultured in the presence of 100% autologous ascitic fluid with the fluid changed twice weekly. The established cell lines, HeLa, HepG2, JO'N, MCF-7, 1847, OVCA433, JAMA2, SKOV3, and TR175, were maintained in DMEM containing 10% FCS and 1% L-glutamine. A2780 cells were maintained in RPMI containing 10% FCS and 1% L-glutamine. All chemicals and culture media were obtained from Sigma (Dorset, UK), unless otherwise stated.
Immunofluorescence for epithelial ovarian morphology Cells were plated on 12-well slides and fixed in 3% paraformaldehyde for 15 min, then stored in cold PBS until stained. Cells were briefly permeabilized with 0.1% Triton X-100 for 5 min, then rinsed thoroughly in PBS. Blocking in 1% BSA-PBS was carried out for 30 min and primary antibody applied (diluted in 0.1% BSA-PBS) for 60 min at room temperature. Details of antibodies used for immunofluorescence, immunohistochemisty, flow cytometry, and western blotting are shown below in Table 1 . After extensive washing in PBS, an FITCconjugated goat anti-mouse Ig was applied for 30 min and the slides kept in the dark. The slides were then extensively washed, Hoechst stained, and mounted. Images were captured using a Zeiss Axioplan microscope and AxioVision v.3.1 software.
Antibody staining of cell surface proteins for flow cytometry Cells were lifted from culture dishes using 0.1% EDTA in PBS and counted. If uncultured cells were used, the cells were placed in 0.1% EDTA for approximately 30 min at 37 1C until a single cell suspension was obtained. A total of 10 5 cells were incubated with primary antibody. An isotype control was used to discriminate positively stained cells. After washing, the cells were incubated with FITCconjugated goat anti-mouse Ig for 30 min at 4 1C in the dark. After further extensive washes, the cells were fixed in 2% formaldehyde and analyzed on an FacScan flow cytometer (Coulter, High Wycombe, UK) within 24 h. This procedure was repeated in triplicate samples three times on cell lines and at least once in triplicate on patient samples.
High expression of the cell surface molecule ( þ þ þ ) was defined as a shift in the histogram from the isotype control of at least one decade in fluorescent intensity. Numerically, this meant that the median fluorescent intensity (MFI) of the sample divided by the MFI of the isotype control was 45. Medium expression ( þ þ ) was defined as a fivefold shift in the histogram and an MFI/MFI isotype control of 3-5. Low expression ( þ ) was defined as MFI/MFI isotype control of 41 to o3. Negative samples (À) were defined as no shift at all and had an MFI/MFI isotype control of o1.
Adenoviral transduction
Recombinant adenovirus serotype 5 with E1 and E3 gene deletions were purchased from Q-Biogene (Cambridge, UK). These contained either the green fluorescent protein (GFP) or lacZ gene driven by the CMV promoter. The Ad5.CMV.GFP was obtained at 9.6 Â 10 11 pfu ml -1 and Ad5.CMVlacZ at 1 Â 10 9 pfu ml -1 . Multiplicity of infection (MOI) was calculated based on the infectious particle number.
Cells were plated at 1 Â 10 5 per well in a 24-well plate and transduced the next day at an MOI of 1 and 10 with Ad5.CMVGFP. Transduction was carried out in RPMI containing 2% FCS and 1% L-glutamine. After transduction for 1 h, the adenovirus was removed, the cells were washed, and incubated for a further 24 h before being analyzed on the FacScan flow cytometer. In Table 2 , þ þ þ indicates transduction of 60-100% of cells with an MOI of 1, þ þ 40-60%, þ 20-40%, and -o20%.
Uncultured cells were transduced by the Ad5.CMVGFP virus in suspension. After the red blood cell lysis buffer was washed out, the cells were counted and 10 5 cells were placed in each tube in the appropriate medium with virus at an MOI of 10 or 1. Cells were placed in tubes containing RPMI with 2% FCS and 1% L-glutamine, 100% autologous ascitic fluid or 1% autologous ascitic fluid diluted in RPMI. After 1 h at 37 1C, the cells were washed and plated in supplemented RPMI medium for 48 h before being analyzed by flow cytometry.
Samples of solid ovarian tumor were extracted from the patient during routine diagnosis. Small pieces of around 3-5 mm 3 were placed in either 0.5 ml of supplemented RPMI medium or autologous ascitic fluid (100%) with 1 Â 10 7 pfu of Ad5.CMVlacZ. After an hour at 37 1C, the samples were washed twice with medium and left for 24 h before being fixed in 3% paraformaldehyde and stained with X-gal as described earlier. 19 Paraffin-embedded sections were cut and examined for adenoviral transduction as shown by the blue X-gal precipitate. ) were also assessed for CAR and integrin expression compared with their ability to be transduced by adenovirus using the same scoring system as for the primary cultures.
Western blotting A total of 10 5 cells were lysed in RIPA buffer with added protease inhibitors. After freeze thawing, the supernatant was centrifuged to remove debris and a Bradford Assay was carried out to measure the amount of protein in the sample. In total, 15 mg of protein from each sample was loaded onto a 10% SDS-PAGE gel in non-denaturing conditions. After electrophoretic transfer onto Hybond-C membrane (GE Healthcare, Buckinghamshire, UK), the manufacturer's protocols were used to hybridize the antibodies. Visualization was either carried out using enhanced chemiluminesence with an HRP-conjugated goat anti-mouse Ig antibody or using the Odyssey system (Li-Cor Biosciences, Nebraska) with an AlexaFluor 680-conjugated goat anti-mouse Ig antibody (Molecular Probes, Eugene, Oregon) to allow quantitation of CAR as a ratio to b-actin-loading control.
Immunohistochemistry for CAR
Sections from paraffin-embedded tissue were dewaxed and rehydrated through graded alcohols. Endogenous peroxidase was blocked using 10% H 2 O 2 for 20 min. Pressure cooking was carried out with vector unmasking solution for 2 min followed by an avidin-biotin block. Blocking in 1% BSA was carried out for 20 min followed by incubation with the CAR antibody (H-300) for 1 h. A biotinylated secondary goat anti-rabbit (Dako, Ely, UK) was applied at 1:500 dilution and incubated for 30 min. Streptavidin/peroxidase incubation was followed by application of the DAB chromogen to visualize the staining and a hematoxylin counter-stain was applied. 
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Statistical analysis
Statistical tests were carried out using GraphPad Prism version 5.01 software for Windows. Shapiro-Wilk normality tests were calculated followed by Wilcoxon's signed rank tests. (Figure 1 ). Ovarian epithelium is the modified pelvic mesothelium covering the ovary and as such it expresses both epithelial and mesenchymal markers. 20 Cytokeratins (CKs) 8, 18, and a pan-CK were used as epithelial markers. Expression of CA125 was also used to show cells of ovarian origin. The expression of CK 5/6 was used as a marker for cells of mesothelial origin. An antibody to smooth muscle was used as a negative control. The results in Figure 1 are representative of four ascitic fluids, two primary tumors, and two pleural effusion samples. HUVEC (endothelial cells) and U251 (glioblastoma cells) were used as negative controls and OVCA433 cells (an ovarian carcinoma cell line) was used as a positive control. OVCA433 and HUVEC cells are shown. The results obtained by immunofluorescence and examination by a gynecological pathologist confirmed that the majority of primary cultures were of epithelial origin. A subset of actively dividing cultures was also examined by metaphase spread to confirm malignancy. A further 41 patient samples were cultured and were found to express high levels of CKs 8 and 18 by gene expression analysis (data not shown). Subsequent attribution of EOC status in further cultures was based on the morphology of the cells. The expression of the adenoviral receptor, CAR, and the integrin a v b 3 , required for internalization of the virus, was also measured by flow cytometry and compared with the adenoviral transduction efficiency ( Table 2 ). All 15 of the patient samples tested were easily transduced with adenovirus and this correlated with a high level of CAR and integrin expression ( Table 2) . The results from cell lines are shown at the end of Table 2 . These cells show variable transduction levels with the adenovirus that seem to correlate closely with expression levels of CAR, but less so with integrin.
Results

Cell
surface markers of EOC are present on short-term cultures of primary cells from ascitic fluid Approximately 80% of cells from the ascitic fluid can be cultured in vitro and approximately 50% of solid tumor samples can be grown successfully as a monolayer culture in our hands. A subset of cultures derived from patient samples were examined by immunofluorescence for a range of markers to determine whether they were of epithelial ovarian morphology
Transduction of short-term cultures of primary cells and established ovarian cancer cell lines
In vitro culture of primary cells increases the level of transduction by adenovirus and the level of CAR expression Other groups had reported the transduction of primary ovarian cancer cells to be low 14 and, therefore, this discrepancy in results warranted further examination. Cells isolated from ascites of two patients were transduced with adenovirus before culture and subsequently at each passage (Figure 3a) . The transduction levels of uncultured cells (p0) were generally low; however, on culture, the levels of transduction rose to those described in Figure 2a . In addition, nine primary cultures that were tested at both p0 and p3 showed a significant increase in transduction with adenovirus after passage, even though eight out of nine initially showed o30% of cells transduced with an MOI of 10 ( Figure 3b ). With passage, one culture showed less than twofold increase in transduction, five showed a three-to ninefold increase, and three showed 410-fold increase. The bars on the graph denote the medians of the two groups, a two-tailed Wilcoxon's signed rank test shows the transduction levels to be significantly different (Po0.005) before and after culture. This increase in transduction correlates with an increase in the expression of CAR observed with passage (Figures 3c and d) .
Autologous ascitic fluid can reduce the ability of adenovirus to transduce primary cells Cells were transduced in the presence of 0 or 100% autologous ascitic fluid at each passage. Representative plots in Figure 4a of one patient sample that show Ad5.CMVGFP was not able to transduce cells in the presence of 100% ascitic fluid compared with 0% ascitic fluid for the hour during which adenovirus was placed on the cells. Nine samples were tested at passage 3 with and without autologous ascitic fluid, one showed no reduction, five showed a small reduction (two to ninefold change), and three showed a large reduction (410-fold change)-see Figure 4b . Thus, the majority of samples tested show a significant reduction in transduction levels in the presence of ascitic fluid. The bars on the graph denote the medians of the two groups, a two-tailed Wilcoxon's signed rank test shows the transduction levels to be significantly different (Po0.005) in the presence or absence of autologous ascitic fluid. This inhibitory factor Adenoviral transduction in ovarian cancer N Ingram et al responsible can be titrated out by dilution of the ascitic fluid to 1% (data not shown) and correlates with the results from Blackwell et al. 18 It was also noted that the expression of CAR itself was maintained from p0 to p2 when cells are grown in 100% autologous ascitic fluid (Figure 4c ). The level of CAR expression was much higher when cells were cultured in supplemented RPMI than in 100% ascitic fluid, although it must be noted that the cells often did not thrive in these conditions after an initial establishment period. Indeed, the cells did not divide and grow at all after passage 2 in 100% autologous ascitic fluid. Solid tumor can be easily transduced by adenovirus Small pieces of tumor were obtained during debulking surgery from four patients; these were transduced with 10 7 pfu Ad5.CMVlacZ virus in the presence (AF) or absence (RPMI) of autologous ascitic fluid. Figure 5 shows representative sections of tumor from these patients stained for lacZ. Three out of four tumor samples were transduced to varying degrees with the virus. Expression of lacZ is high in the periphery of these tumors and seems to penetrate two or three cell layers into the tumor. One patient sample (number 2) was not well transduced with only the occasional lacZ-positive cell. In general, solid tumors can be transduced at the periphery with non-replication competent adenovirus. The expression of CAR was observed in all samples and it shows in more detail with patient 1. However, this transduction was not seen when addition of the adenovirus was carried out in the presence of autologous ascitic fluid (100% AF), indicating that inhibitory factors are preventing entry of the virus, despite the expression of CAR.
Discussion
Many laboratories are developing gene therapy strategies for ovarian cancer using adenoviral vectors. This study aimed to elucidate some of the factors that may influence successful administration of adenoviral-delivered gene therapy to the peritoneal cavity of patients with ovarian cancer.
Primary cultures derived from ascites and solid tumors obtained from ovarian cancer patients retained the mesoepithelial malignant morphology of ovarian cells determined by immunestaining of keratin filaments and CA125 as defined by Auersperg et al. 20 Transduction with replication-incompetent adenovirus serotype 5 was performed and the status of CAR and the a v b 3 integrin was examined. Primary cultures grown in supplemented RPMI were easily transduced with adenovirus and this correlated with high CAR and integrin expression levels. However, the level of transduction of these cells was reduced in the presence of autologous ascitic fluid. This finding correlates with work by Hemminki et al. 22 showing that neutralizing antibodies are present in ascitic fluid that can block transduction by adenovirus. This study of serum and ascites fluid from patients undergoing an adenoviral gene therapy trial showed an inverse but not statistically significant correlation between pre-existing neutralizing antibodies and transgene expression. A decrease in transgene expression was observed with an increase in the titer of neutralizing antibodies, but not Red blood cells have also been shown to bind to adenovirus type 5 leading to a reduction in available viral particles for transduction. 23 Cichon et al. showed a strong hemaglutination reaction between adenovirus serotype 5 and human blood, but not with murine blood. Therefore, the presence of red blood cells in early culture of these cells because of non-optimal lysis may also have a function in these lower levels of adenoviral transduction. The results from in vivo animal studies should, therefore, be viewed with caution, as they may not accurately reflect the sequestration of adenovirus by red blood cells as it occurs in human beings. It was noted that red blood cell lysis was inefficient in very bloody ascites, despite repeated applications, and, therefore, could have contributed to a decrease in transduction levels.
Expression of CAR and transduction levels was relatively low in uncultured cells from the majority of patient samples compared with later passage cells grown in supplemented RPMI (Figure 3b ). Hemminki et al.
14 also found this phenomenon in TAG-72-selected cells grown as spheroids. Cells grown in monolayer in autologous AF contained similar levels of CAR to uncultured cells (Figure 4c) . Presumably, the growth of cells in monolayer culture in RPMI upregulates CAR to the levels shown in Figure 4c . CAR is a transmembrane component of tight junctions 24 and it is likely that expression is upregulated in monolayer culture compared with free-floating spheroids or single cells. However, this does not explain the lack of increase in CAR expression when cells were cultured in ascitic fluid in monolayer. Therefore, there must be other factors within RPMI and FCS that specifically affect CAR expression.
The transduction of solid tumor specimens obtained during surgery shows that they can be easily transduced by adenovirus, particularly cells at the periphery, using a replication-defective adenovirus. Consistent with this observation, clear expression of CAR has been shown by immunohistochemistry of solid ovarian tumor 13, 25 and is also shown here. A replication-competent adenovirus is, therefore, needed to allow penetration and spread within the solid tumor as replication-incompetent viruses are limited to cells at the periphery of a solid tumor mass. The use of these adenoviruses is currently being examined for use with existing ovarian cancer treatments. 26 It should be possible to use cultured cells from ascites samples to test gene therapy strategies without the need for further manipulation of the receptor as both cultured ascites and solid tumor readily transduce. However, retargeting strategies may be required to evade neutralizing antibodies and avoid uptake by erythrocytes. Retargeting can also be used to restrict transduction of non-target organs. Possible retargeting receptors for adenoviral entry include EGFR, 27 CD40, 28 and the vascular endothelial growth factor receptors. 29 Preliminary data from this group suggests that CD40 may be the most stable in culture and in the presence of autologous ascitic fluid. Recent data has shown that liver cells are transduced through a complex involving coagulation factor X and the adenoviral hexon rather than the classical fiber knob-binding CAR. 30 It may, therefore, be more beneficial to manipulate the hexon proteins to avoid non-target cell transduction or use alternative serotypes with modified fiber knobs.
This study shows that ascitic tumor cells and primary solid tumor deposits can be transduced by adenovirus. However, the presence of autologous ascitic fluid is refractory to this process. The authors suggest that drainage of ascitic fluid and peritoneal lavage should be considered before clinical trials involving intraperitoneal administration of replication-competent adenoviral vectors.
